T&L Co., Ltd.
340570.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$632.55B
Close$
$58692.23
128.4% upside
Current Fair Value
128.4% upsideUndervalued by 128.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $632.55 Billion |
|---|---|
| Enterprise Value | $596.99 Billion |
| Dividend Yield | $750.00 (2.74%) |
| Earnings per Share | $2362.5 |
| Beta | 0.37 |
| Outstanding Shares | 16,031,531 |
Return
| Return on Equity | 22.65% |
|---|---|
| Return on Assets | 20.05% |
| Return on Invested Capital | 28.28% |
Valuation & Multiples
| P/E Ratio | 8.66 |
|---|---|
| PEG | 5.6 |
| Price to Sales | 2.35 |
| Price to Book Ratio | 1.84 |
| Enterprise Value to Revenue | 3.41 |
| Enterprise Value to EBIT | 9.38 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$57.27 B
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$47.00 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About T&L Co., Ltd.
250 employees
CEO: Yoon-So Choi Operating out of South Korea, T&L Co., Ltd. specializes in developing and marketing a variety of medical and polymer-based materials. The company's diverse product portfolio features chemical compounds like water-borne resins, hardeners,...